Positives

• GHRP-6 may be of interest to patients dealing with appetite loss, muscle wasting, poor recovery, or sleep disruption after Long COVID or ME/CFS (Wikipedia).
• Its chronic-illness relevance is speculative and mostly tied to growth-hormone signaling, appetite, and recovery biology rather than direct symptom relief (Wiley).

Negatives

• There is not strong evidence that GHRP-6 improves PEM, brain fog, dysautonomia, MCAS, Lyme, or chronic fatigue (Wikipedia).
• Hormonal shifts, appetite spikes, fatigue, prolactin/cortisol effects, and glucose changes may be poorly tolerated by some patients (Wiley).

Hurdles & Side Effects

• No standard approved Long COVID or ME/CFS protocol exists, and many products are sourced from unregulated peptide markets (Wikipedia).
• Patients with glucose instability, hormone-sensitive conditions, or POTS-related food/fluid challenges would need clinician oversight (Wikipedia).